Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. S 2 c d
Lee H et al. (2020)
|
Xtr Wt + chrd.1 CRISPR
NF11 (in situ hybridization)
|
|
|
|
Fig. S 4 e f
Lee H et al. (2020)
|
Xtr Wt + nog CRISPR
NF11 (in situ hybridization)
|
|
|
|
Fig. S 4 e f
Lee H et al. (2020)
|
Xtr Wt + nog CRISPR + rspo2 CRISPR
NF11 (in situ hybridization)
|
|
|
|
Fig. S 4 c d e f
Lee H et al. (2020)
|
Xtr Wt + rspo2 CRISPR
NF11 (in situ hybridization)
|
|
|
|
Fig. S 4 c d
Lee H et al. (2020)
|
Xtr Wt + rspo2 CRISPR + chrd.1 CRISPR
NF11 (in situ hybridization)
|
|
|
|
Fig. 7 A row 2 col 1
Jalvy S et al. (2019)
|
Xla Wt + lif
NF 12.5 (RT-PCR)
|
|
|
|
Fig.2 D
Nakamura Y et al. (2016)
|
Xla Wt + wnt8a MO
NF10.5 (whole-mount microscopy)
|
|
|
|
Fig.2 C
Nakamura Y et al. (2016)
|
Xla Wt + wnt8a MO
unspecified stage (RT-PCR)
|
|
|
|
fig.3.b
Sun G et al. (2015)
|
Xla Wt + ctdspl MO
NF10.5 (morphology)
|
|
|
|
Fig.6.A
Iwasaki Y and Thomsen GH (2014)
|
Xla Wt + bmp4 + animal cap explant
NF10.5 (RT-PCR)
|
|
|